Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cobra, KAHR Extend Collaboration | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Cobra, KAHR Extend Collaboration

Will develop both KAHR-101 and KAHR-102

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Cobra Biologics and KAHR Medical Limited will continue their partnership. The move will allow Cobra to advance both KAHR-101 and KAHR -102 for future preclinical and clinical testing using its maxXpress service.

MaxXpress enable rapid clone selection and production by combining UCOE protein expression technology with the experience and expertise of Cobra Biologics’ cell line development team. Cobra Biologics will also carry out the process development and scale up for GMP production of both KAHR-101 and KAHR-102.
 
Peter Coleman, chief executive officer at Cobra Biologics, said, “I am delighted to extend our partnership with KAHR, which has been strengthened over a number of years due to the excellent working relationship between both technical teams and we look forward to its continuation.”
 
Dr. Noam Shani, chief executive officer of KAHR Medical, added, “It has been a pleasure working with Cobra Biologics over the years and we have enjoyed the interaction and responsiveness of its team. We hope to build on our successful partnership with the fast-track development of both KAHR-101 and KAHR-102.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics